118 related articles for article (PubMed ID: 3604856)
1. Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration.
Rector TS; Olivari MT; Levine TB; Francis GS; Cohn JN
Am Heart J; 1987 Jul; 114(1 Pt 1):148-52. PubMed ID: 3604856
[No Abstract] [Full Text] [Related]
2. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group.
Francis GS; Cohn JN; Johnson G; Rector TS; Goldman S; Simon A
Circulation; 1993 Jun; 87(6 Suppl):VI40-8. PubMed ID: 8500238
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of congestive heart failure and predictors of mortality.
Cohn JN; Rector TS
Am J Cardiol; 1988 Jul; 62(2):25A-30A. PubMed ID: 3389302
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure.
Isnard R; Pousset F; Trochu J; Chafirovskaïa O; Carayon A; Golmard J; Lechat P; Thomas D; Bouhour J; Komajda M
Am J Cardiol; 2000 Aug; 86(4):417-21. PubMed ID: 10946035
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators.
Benedict CR; Shelton B; Johnstone DE; Francis G; Greenberg B; Konstam M; Probstfield JL; Yusuf S
Circulation; 1996 Aug; 94(4):690-7. PubMed ID: 8772689
[TBL] [Abstract][Full Text] [Related]
6. Impaired suppression of plasma norepinephrine during head-down tilt in patients with congestive heart failure.
Goldsmith SR
Am Heart J; 1991 Jul; 122(1 Pt 1):104-7. PubMed ID: 2063731
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of death in patients with congestive cardiac failure: the change in plasma norepinephrine and its relation to sudden death.
Francis GS; Boosalis PJ
Cardioscience; 1990 Mar; 1(1):29-32. PubMed ID: 2102793
[TBL] [Abstract][Full Text] [Related]
8. Plasma norepinephrine in congestive heart failure.
Thomas JA; Marks BH
Am J Cardiol; 1978 Feb; 41(2):233-43. PubMed ID: 203177
[No Abstract] [Full Text] [Related]
9. Transcardiac increase in norepinephrine and prognosis in patients with chronic heart failure.
Tsutamoto T; Nishiyama K; Sakai H; Tanaka T; Fujii M; Yamamoto T; Yamaji M; Horie M
Eur J Heart Fail; 2008 Dec; 10(12):1208-14. PubMed ID: 18977693
[TBL] [Abstract][Full Text] [Related]
10. Insulin-mediated glucose uptake in congestive heart failure.
Doehner W; Anker SD
Am J Cardiol; 1999 Sep; 84(6):761-2. PubMed ID: 10498157
[No Abstract] [Full Text] [Related]
11. Effects of ibopamine on the increase in plasma norepinephrine levels during exercise in congestive heart failure.
van Veldhuisen DJ; Girbes AR; van den Broek SA; de Graeff PA; van Gilst WH; Lie KI
Am J Cardiol; 1993 Apr; 71(11):992-4. PubMed ID: 8465795
[No Abstract] [Full Text] [Related]
12. Plasma beta-endorphin response to exercise in patients with congestive heart failure.
Perna GP; Modoni S; Valle G; Stanislao M; Loperfido F
Chest; 1997 Jan; 111(1):19-22. PubMed ID: 8995987
[TBL] [Abstract][Full Text] [Related]
13. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity.
Hasking GJ; Esler MD; Jennings GL; Burton D; Johns JA; Korner PI
Circulation; 1986 Apr; 73(4):615-21. PubMed ID: 3948363
[TBL] [Abstract][Full Text] [Related]
14. Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure.
Francis GS; Goldsmith SR; Ziesche SM; Cohn JN
Am J Cardiol; 1982 Apr; 49(5):1152-6. PubMed ID: 7064841
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure.
Tsutamoto T; Hisanaga T; Fukai D; Wada A; Maeda Y; Maeda K; Kinoshita M
Am J Cardiol; 1995 Oct; 76(11):803-8. PubMed ID: 7572659
[TBL] [Abstract][Full Text] [Related]
16. Prognostic importance of insulin-mediated glucose uptake in aged patients with congestive heart failure secondary to mitral and/or aortic valve disease.
Paolisso G; Tagliamonte MR; Rizzo MR; Gambardella A; Gualdiero P; Lama D; Varricchio G; Gentile S; Varricchio M
Am J Cardiol; 1999 May; 83(9):1338-44. PubMed ID: 10235092
[TBL] [Abstract][Full Text] [Related]
17. Effects of right lateral decubitus position on plasma norepinephrine and plasma atrial natriuretic peptide levels in patients with chronic congestive heart failure.
Miyamoto S; Tambara K; Tamaki Si; Nagaya N; Hasegawa K; Nohara R; Miwa K; Fujita M
Am J Cardiol; 2002 Jan; 89(2):240-2. PubMed ID: 11792354
[No Abstract] [Full Text] [Related]
18. Norepinephrine kinetics during orthostatic stress in congestive heart failure.
Davis D; Sinoway LI; Robison J; Minotti JR; Day FP; Baily R; Zelis R
Circ Res; 1987 Oct; 61(4 Pt 2):I87-90. PubMed ID: 3652408
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of plasma endothelin-1 in patients with chronic heart failure.
Pousset F; Isnard R; Lechat P; Kalotka H; Carayon A; Maistre G; Escolano S; Thomas D; Komajda M
Eur Heart J; 1997 Feb; 18(2):254-8. PubMed ID: 9043842
[TBL] [Abstract][Full Text] [Related]
20. Return of plasma norepinephrine to normal after resolution of congestive heart failure in congenital heart disease.
Ross RD; Daniels SR; Schwartz DC; Hannon DW; Kaplan S
Am J Cardiol; 1987 Dec; 60(16):1411-3. PubMed ID: 3687797
[No Abstract] [Full Text] [Related]
[Next] [New Search]
